Paul D. Callaghan

Statistics

Publications

Citations

2.1K

H-Index

Active since

1981

Affiliations

Australian Nuclear Science and Technology Organisation(Current)

The University of Sydney

The University of Texas at San Antonio Health Science Center

The University of Adelaide

UNSW Sydney

Paul D. Callaghan is an author at Australian Nuclear Science and Technology Organisation specializing in pharmacology, neuropharmacology, and neuroscience.

ORCID

Publications per year

1981–2024

Publications

Adolescent Rats Find Repeated Δ9-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure

Heidi Quinn, Izuru Matsumoto, Paul D. Callaghan et al. · Neuropsychopharmacology · 2007 · 290 citations · Full text

Life Sciences, Neuroscience, Pharmacology +11

Positron emission tomography and functional characterization of a complete PBR/TSPO knockout

Richard B. Banati, Ryan J. Middleton, Ronald Ho Yeung Chan et al. · Nature Communications · 2014 · 240 citations · Full text

Medicine, Neuroscience, Pharmacology +14

A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (“ecstasy”)

Murray R. Thompson, Paul D. Callaghan, Glenn E. Hunt et al. · Neuroscience · 2007 · 237 citations

Medicine, Neuroscience, Pharmacology +14

Cocaine Increases Dopamine Uptake and Cell Surface Expression of Dopamine Transporters

Lynette C. Daws, Paul D. Callaghan, José A. Morón et al. · Biochemical and Biophysical Research Communications · 2002 · 208 citations

Life Sciences, Neurobiology, Neuroscience +15

PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy

Stefanie Dedeurwaerdere, Paul D. Callaghan, Tien Pham et al. · EJNMMI Research · 2012 · 92 citations · Full text

Medicine, Neurology, Neuroscience +12

1–5 of 37